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Cystatin BEPM1 is a rare progressive myoclonus epilepsy accompanied by apoptosis in the cerebellum of patients. Muta-
tions in the gene of steﬁn B (cystatin B) are responsible for the primary defect underlying EPM1. Taking steﬁn
B aggregates as a model we asked what comes ﬁrst, protein aggregation or oxidative stress, and how these
two processes correlate with cell death.
We studied the aggregation in cells of the steﬁn B wild type, G4Rmutant, and R68X fragment before (Ceru et al.,
2010, Biol. Cell). The present study was performed on two more missense mutants of human steﬁn B, G50E and
Q71P, and they similarly showed numerous aggregates upon overexpression. Mutant- and oligomer-dependent
increase in oxidative stress and cell death in cells bearing aggregateswas shown. On the other hand, therewas no
correlation between the size and number of the aggregates and cell death.We suggest that differences in toxicity
of the aggregates depend on whether they are in oligomeric/protoﬁbrillar or ﬁbrillar form. This in turn likely
depends on the mutant's 3D structure where unfolded proteins show lower toxicity. Imaging by transmission
electron microscopy showed that the aggregates in cells are of different types: bigger perinuclear, surrounded
by membranes and sometimes showing vesicle-like invaginations, or smaller, punctual and dispersed through-
out the cytoplasm. All EPM1mutants studied were inactive as cysteine proteases inhibitors and in this way con-
tribute to loss of steﬁn B functions. Relevance to EPM1 disease by gain in toxic function is discussed.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Epilepsy is as a common and diverse set of chronic neurological dis-
orders characterized by enduring propensity to generate epileptic sei-
zures. Idiopathic epilepsy syndrome is deﬁned as purely epilepsy with
no clear underlying structural brain lesions. It is therefore suspected
that multiple gene abnormalities may be the route of such epilepsies
togetherwithmetabolic and environmental inﬂuences. Genetic epilepsies
account for only about 1% of all epilepsies but they present themselves
with severe symptoms and poor outcome. The most commonly mutated
genes in genetic epilepsies are for protein subunits of voltage-gated (e.g.
sodium-gated or calcium-gated) or ligand-gated ion channels [1]. Thesey of type 1; TEM, transmission
stry, Molecular and Structural
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Cancer Research Center, Im
. This is an open access article undermutations can cause impaired excitability of inhibitory γ-aminobutyric
acid-ergic (GABAergic) interneurons [2] or hyperexcitability ofﬁring neu-
rons [3]. In both cases, currents in the brain are disrupted.
Other mutations rather than channel-related ones have been found
for certain rare epilepsies. Progressive myoclonus epilepsies (PMEs)
are a group of different genetic generalized epilepsies with symptoms
such as myoclonus and tonic-clonic seizures, dementia and progressive
neurodegeneration of grey matter in the cerebrum and cerebellum (for
reviews see [4,5]). PMEs can be divided pathogenically into two groups:
non-lysosome related, such as Lafora disease, and lysosome related,
such as Unverricht–Lundborg disease (progressive myoclonus epilepsy
of type 1, EPM1), most common of all PMEs and in the focus of our re-
search. For all types of PMEs, accumulation of proteinaceous inclusions
or aggregates has been discovered [6–8].
EPM1 or Unvericht–Lundborg disease is caused by mutations in the
gene encoding steﬁn B (cystatin B) (CSTB), primarily known as a cyste-
ine protease inhibitor [9,10]. The most common change found in the
steﬁn B gene is the dodecamer repeat expansion in the promoter region
[11] which leads to reduced mRNA and consequently reduced protein
levels. The CSTB gene is located in chromosome 21q22.3 and altogether
14 different mutations of this gene have been reported to underlie
EPM1 [12–15]. Pathology results in a marked loss of Purkinje cells inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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cortical thickness [17] and white matter loss throughout [18].
Mutations in two genes have been reported in CSTBmutation nega-
tive patients presenting with symptoms similar to EPM1. Berkovic and
co-workers found a locus on the human chromosome 12, termed
EPM1B. Further studies by Bassuk et al. [19] showed that mutations in
the prickle-like protein 1 precursor PRICKLE1, a gene encoding a protein
involved in the non-canonical Wnt signaling pathway, are the cause of
the progressivemyoclonus epilepsy of type 1B (EPM1B) [19]. Mutations
in the lysosome membrane protein 2, SCARB2 [20], have been reported
by the same authors. Deciphering the signaling pathways of these
proteins will likely intersect with those of steﬁn B and will add to our
understanding of EPM1 [19,21].
In most cases the EPM1 mutants produce lower expression of the
steﬁn B protein, whosemost well-known function is inhibition of the
cysteine proteases—cathepsins B, H, K, L and S [22–24]. The physio-
logical function of steﬁn B in the molecular pathogenesis of the dis-
ease is not known. Loss of function signs are observed in patients,
which are relatively well recapitulated in steﬁn B knockout (KO)
mice. Although the protective role of steﬁn B against apoptosis was
suggested [25–27], it is still unclear how the reduced protein levels
could lead to myoclonus and/or the epileptic phenotype with tonic-
clonic light sensitive seizures. It was suggested that the primary
steﬁn B deﬁcit could trigger several secondary processes, such as
overstimulation of serotoninergic transmission [28] or a defect in
dopamine transmission [29], which would in turn cause the seizure
phenotype. It was recently shown in steﬁn B KOmice that there is lo-
calized glial activation in brain regions with signiﬁcant neural loss
that precedes the appearance of myoclonus which conﬁrms the pa-
thology of glial excessive activation [30]. Genes involved in increased
apoptosis and glial activation were shown to be overexpressed [31].
In accordance to other neurodegenerative conditions, abundant
gliosis appears in these regions [32].
It is therefore important to clarify protein's alternative function(s). It
was reported that steﬁn B is part of themultiprotein complex regulating
cytoskeleton [33] and that the protein is involved in protection against
oxidative stress [34,35] and possesses putative chaperone-like function
[36,37]. Steﬁn B is also known to bind copper and could thus have a role
in preventing oxidative stress [38] and is proposed to play a role in au-
tophagy ([7] and submitted manuscript). Its neuroprotective function
was suggested due to increased expression in the forebrain neurons
after seizure activity in rats [39]. Steﬁn B also binds to histones and
indirectly regulates the cell cycle through inhibition of cathepsin L in
the nucleus [40]. If such functions get lost in EPM1, the consequences
could well lead to neurodegeneration.
Additionally to the loss of function that occurs, gain in toxic function
of some EPM1 steﬁn B missense mutant aggregates may play a role, as
proposed by us before [41]. Steﬁn B in its wild type (wt) form is an
amyloidogenic protein and it has served as an appropriate model for
studies of amyloid formation [42,43]. Protein misfolding and aggrega-
tion are at the core of the so called conformational disorders [44,45].
The conformational disorders involve protein conformational changes
leading to alternatively folded (i.e. misfolded and intermediate) states,
rich in β secondary structure that have a high tendency to aggregate
or forms amyloids. Neurodegenerative diseases such as Parkinson's
(PD), Alzheimer's (AD), Huntington's disease (HD) and various other
dementias, like amyotrophic lateral sclerosis (ALS) and prion diseases,
all belong to the conformational disorders.
Intracelullar and cytoplasmic inclusions were found in the brain
of one EPM1 patient with the promote extension mutation [46].
The authors reported that the inclusions consisted of the lysosomal
protein cathepsin B, transmembrane protein CD68 (cluster of differ-
entiation 68) or RNA-binding FUS. Related proteins were found in
mass spectormetry experiments of insoluble cell fractions from
steﬁn B knockout mice, performed in our department (submitted
manuscript).A consensus prevails that amyloid ﬁbril formation is a generic prop-
erty of proteins [47]. It was shown that even some α helical proteins
such asmyoglobin can formamyloid-likeﬁbrils, undergoingα toβ tran-
sition. Fibril formation occurs also with proteins which are natively un-
folded, intrinsically disordered [48], or are predominantly in β sheet.
Different proteins probably follow different pathways towards amyloid
ﬁbrils, depending on the structural class [44,49].
Size and morphology of the preﬁbrillar wt steﬁn B aggregates have
been determined and are in agreementwith other amyloid formingpro-
teins [50]. Endogenous protein can form oligomers intracellularly [51]
but these preﬁbrillar oligomers can also be toxic to cells [50,52]. A con-
sensus is reached that themechanismof amyloid cytotoxicitymost like-
ly involves membrane interaction and perforation [53]. As observed for
a number of amyloid forming proteins, steﬁn B binds to acidic phospho-
lipid bilayers and is internalized through the plasma membrane where
it lowers cell viability [50,52,54].
We have shown that wt steﬁn B, missense G4R and fragmented
R68X EPM1 mutants aggregate upon overexpression in cells [55]. In
this paper, additional experiments on two missense EPM1 mutants
G50E and Q71P are presented, which conﬁrm that they also aggregate
to a much greater extent than the wt. By correlating size and number
of the aggregates with cell death and oxidative stress, we here present
data that show that smaller, punctual aggregates are more toxic to
cells and that oxidative stress and cell death correlate for those EPM1
missense mutants, which increase oxidative stress most. We think
that aggregate toxicity may contribute to EPM1 disease development
and neurotoxicity and discuss this.
2. Materials and methods
2.1. Materials
Primers, all horseradish peroxidase-conjugated secondary antibod-
ies and propidium iodide (PI) were purchased from Sigma Aldrich (St.
Louis, MO, USA). LeuleuOMe was supplied by Bachem (Bubendorf,
Switzerland). Lipofectamine® 2000 was from Invitrogen (Carlsbad,
CA, USA). Pfu DNA polymerase for the polymerase chain reaction
(PCR) was purchased from Fermentas (Vilnius, Lithuania). AnnexinV–
PE (phycoerythrin) was purchased from BD Biosciences (Franklin
Lakes, NJ, USA). Gelatine and sucrose were from Merck (Whitehouse
Station, NJ, USA). Uranyl acetate was purchased at SPI Supplies (West
Chester, PA, USA). Protease inhibitor cocktail tablets (25×)were provid-
ed by Roche (Basel, Switzerland). Pierce® BCA protein assay kit was
purchased from Thermo Fisher Scientiﬁc (Waltham, MA, USA).
For cell culture experiments, Dulbecco's modiﬁed Eagle's medium
with L-glutamine, Ham's F12, fetal bovine serum (FBS), penicillin/
streptomycin (100×), 1× Dulbecco's phosphate buffer saline (PBS),
glutaMAXTM (all PAA Laboratories GmbH, Pasching, Austria) and
TrypLE™ Select (Gibco, Invitrogen, Carlsbad, CA, USA)were used. Bodipy
581/591 C11, MitoSOXTM Red, and Prolong Antifade reagent were from
Molecular Probes (Invitrogen, Carlsbad, CA, USA). Polyclonal antibodies
for steﬁn B and PCNA were purchased from Abcam (Cambridge, UK)
and Santa Cruz (Dallas, TX, USA), respectively.
2.2. Cloning
Mutagenesis was performed by PCR on a 2720 Thermo Cycler
PCR System (Applied Biosystems, Foster City, CA, USA) using a
QuickChange® II Site-Directed Mutagenesis kit (Stratagene, Agilent
Technologies, Inc., Santa Clara, CA, USA) and Pfu DNA polymerase.
Mutagenesis was performed using a template with complementary
DNA gene for human steﬁn B (C3E31) (NM_000100.2) with or
without a T-Sapphire tag on the C terminus [55]. For the R68X
mutant chemically synthesized gene was inserted via BamHI and
XhoI restriction sites in a pcDNA3 vector (Invitrogen, Carlsbad, CA,
USA).
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5′-CGAGGTCATGATGTGCCGGGCGCCCTCCGCCAC-3′ and
5′-GTGGCGGAGGGCGCCCGGCACATCATGACCTCG-3′ (G4R mutant);
5′-AGCCAGGTGGTCGCGGAGACAAACTACTTCATC-3′ and
5′-GATGAAGTAGTTTGTCTCCGCGACCACCTGGCT-3′ (G50E mutant);
5′-CACCTGCGAGTGTTCCCATCTCTCCCTCATGAA-3′ and
5′-TTCATGAGGGAGAGATGGGAACACTCGCAGGTG-3′ (Q71P mutant).
DNA sequenceswere conﬁrmed using Sanger sequencing (BigDyeTM
terminator kit) and resolved with Automatic Sequencer 3730XL
(Applied Biosystems, Foster City, CA, USA) in Macrogen (Rockville,
MD, USA).
2.3. Expression in Escherichia coli (E. coli) and puriﬁcation procedure
Recombinant steﬁn B wt and mutants were produced in E. coli and
puriﬁed according to published procedures [56,57].
2.4. BANA test
To evaluate the inhibitory activity of steﬁn B, BANA test was per-
formed. Steﬁn B monomers, dimers, tetramers and oligomers were di-
luted in BANA buffer (0.1 M phosphate buffer, 1.5 mM EDTA, pH 6.0)
so A280 was 0.5. Papain was diluted in the same buffer to 0.02 mg/ml
(0.5 μM). Eight different molar ratios [E]:[I] were prepared: 1:45, 1:22,
1:11, 1:4, 1:2, 1:0.2. Firstly, papain was activated with 5 mM cysteine
for 5 min at 37 °C. Next, BANA substrate was added to the reaction
mixture in 2 mM ﬁnal concentration and incubated for 10 min at
37 °C. The reaction was stopped with a stop reagent (1 volume of re-
agent III:1 volume of color reagent) and incubated at room temperature.
Absorbancewasmeasured at 520 nmon a Lambda 18UV/VIS spectrom-
eter (Perkin-Elmer, Waltham, MA, USA). Reagent III consisted of
10 mM p-chloromercurybenzoic acid and 50 mM EDTA at pH 6.0.
Color reagent consisted of 3 mM Fast Garnet GBC salt in 4% Brij 35,
pH 6.0.
2.5. Fibrillation kinetics
ThT dye was used to determine the presence of amyloid-like ﬁbrils.
Fluorescence at 482 nm (upon excitation at 440 nm) was measured
using a LS 50 B luminescence spectrometer (Perkin-Elmer, Waltham,
MA, USA). Samples were prepared as described in [57].
2.6. Cell culture and stable and transient transfections
HEK293T (human embryonic kidney) cells were grown in DMEM
medium, SH-SY5Y (neuroblastoma) cells in DMEM/HAM'S F12medium
(1:1) supplemented with 1% (v/v) of non-essential amino acids (NEAA)
and CHO (Chinese hamster ovarian) in HAM'S F12 medium. All media
were additionally supplemented with 1% (v/v) GlutaMAXTM, 10% (v/v)
FBS and 1% (v/v) penicillin/streptomycin. Cells were grown in Petri
dishes at 37 °C in 5% CO2. Cells grown on 15 mm coverslips (SH-SY5Y)
or in 10 cm petri dishes (CHO) were transiently transfected using Lipo-
fectamine® 2000, according to the manufacturer's instructions. For sta-
ble transfection, transfected SH-SY5Y cells were transferred to selective
medium containing 0.2 μg/ml geneticin 48 h after transfection. Cells
were fed with selective medium every 3–4 days until geneticin-
resistant foci could be identiﬁed. Afterwards, cells were diluted at
least twice (1:3) and grown from a heterogeneous population.
2.7. Cell lysates
For protein expression analysis, HEK293Twere lysed after 24 h after
transfection and overexpression. Radioimmunoprecipitation assay
(RIPA) buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 0,1% SDS, 1%deoxycholate, 1% Triton X-100, 5 mM EDTA, and 1× protease inhibitor
cocktail) was used. Cells were scrapped and left on ice for 30 min. Cell
lysates were clariﬁed by centrifugation at 10000 × g for 20 min at
4 °C. Protein concentrations of the supernatants were determined by
BCA assay and the absorbance was measured at 562 nm using a
spectrophotometer.2.8. Fluorescence microscopy
Samples for ﬂuorescent imaging of lipid peroxidationwere observed
with an Olympus IX81 microscope (Olympus, Center Valley, PA, USA)
and 60× oil objective. Images were recorded by ORCA-R2 camera (Ha-
mamatsu Photonics, Hamamatsu City, Japan), using Cell F software.
Green and red emission were ﬁltered using U-N49002 and U-N41002
ﬁlter cubes (Chroma technology) and ﬂuorescence signals were
separately recorded with the ORCA-R2 camera. Confocal images were
taken at the Center of Excellence in Nanoscience and Nanotechnology
– CO Nanocenter, Ljubljana, Slovenia. Leica TCS SP5 X confocal micro-
scope (Leica Microsystems GmbH,Wetzlar, Germany) was used for op-
tical slicing (60×oil objective, NA= 1.4). T-Sapphirewas excited at 488
nmwithwhite light laser (470–670nm) and the emission signalwas re-
corded using a photomultiplier detector (PMT). At the same time differ-
ential interference contrast (DIC) images were taken. Leica LAS AF
software (Leica Microsystems GmbH, Wetzlar, Germany) was used to
process the images.2.9. Transmission electron microscopy (TEM)
TEM images of protein samples were taken at the National Institute
of Biology, Ljubljana, Slovenia. Samples were observed with a Philips
CM 100 transmission electron microscope (Philips/FEI Corporation,
Eindhoven, Holland) operating at 80 kV and prepared as described pre-
viously [57]. The thickness ofﬁbrils wasmeasured in DigitalMicrograph
software (Gatan, Pleasanton, CA, USA) that was beforehand calibrated
according to manufacturer's instructions.
Cell samples were ﬁxedwith 4% paraformaldehyde at room temper-
ature for 2 h. Mixture of growthmedium and ﬁxative was removed and
the pellet embedded in 10% gelatin. Gelatine was solidiﬁed on ice and
cells excised into small blocks, later on immersed in 2.6 M sucrose in
0.1 M phosphate buffer and inﬁltrated at 4 ºC overnight. Cryoprotected
cells were mounted on specimen carriers and stored in liquid nitrogen.
Trimming (at−90 °C) and sectioning (−120 °C) of frozen blocks were
performed with Leica EM FC6 ultramicrotome (Leica Microsystems
GmbH, Wetzlar, Germany) for cryosectioning. Ultrathin cryosections
(70 nm) were cut using diamond cryo-immuno knife (Diatome, Biel,
Switzerland). Sections were collected and thawed on droplets of pick-
up solution (1:1 mixture of 2.3 M sucrose and 2%methyl cellulose). Re-
trieved ultrathin sections of cells were put on carbon-coated Formvar
ﬁlm spread over copper grids (Agar Scientiﬁc, Elektron Technology UK
Ltd., Essex, UK). For immunogold labeling sections were incubated
with polyclonal rabbit anti-human steﬁnB antibody in blocking solution
(2% BSA in PBS) for 30min. PBSwas used for extensive rinsing after each
incubation step. Sections were further incubated with Protein A-gold
(10 nm) for 20 min according to the producer's instructions (Cell Mi-
croscopy Centre, University Medical Centre Utrecht). Controls omitting
the primary antibody were also performed. All immunoreagents were
centrifuged at 16,000 × g (at 4 °C) prior to their use with cell sections.
Sections were contrasted with 0.4% uranyl acetate in solution with
1.8% methyl cellulose (pH 4). Uranyl contrasted the cell proteins but
not the lipids so the membranes appeared white on TEM micrographs.
Contrasted cellswere observed at 150 kVwith JEM-2100 LaB6 transmis-
sion electron microscope (Jeol Ltd., Tokyo, Japan) at the Centre for Elec-
tronMicroscopy, Jožef Stefan Institute, Ljubljana, Slovenia. Micrographs
were taken using Gatan digital camera andDigitalMicrograph software.
Fig. 1. ThT ﬂuorescence emission intensity at 482 nm plotted as a function of time. Fibrilla-
tion reaction of the wt steﬁn B (stars), G50E (blank squares) and Q71P (black diamonds)
mutant. In all cases, protein concentration was 34 μM. Fibrils were grown in the pH 4.8 ac-
etate buffer in the presence of 9% TFE andwere diluted into ThT buffer at different times of
ﬁbril growth. Arrows mark different time points when samples were taken for TEM analy-
sis. Results of one representative experiment are shown.
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Stably transfected SH-SY5Y cell were analyzed by ﬂow cytometry on
FACSCaliburTM (BD Biosciences, Franklin Lakes, NJ, USA)with CellQuest
software (version 3.3). At least 10000 cells were acquired for each
measurement with three or four parallels and experiments were inde-
pendently performed three times. The rest of the method was the
same as described [55].
2.11. Caspase-3-like activity
Caspase-3-like activity was measured by the DEVDase assay, in
which Ac-DEVD-AFC (Bachem, Bubendorf, Switzerland) is a ﬂuorogenic
substrate cleaved by caspase-3 but also by caspases-6, 7, 8 and 10 [58].
Cell lysates were prepared in caspase lysis buffer (50 mM HEPES,
200 mM NaCl, 10% saccharose, 0.1% CHAPS, 5 mM MgCl2, 0.02% BSA,
1% NP-40, 0.5% Triton X-100). Cell lysates and DEVD substrate were di-
luted in caspase buffer (same as caspase lysis buffer but without deter-
gents NP-40 and Triton X-100) and separately incubated at 37 °C for
10 min. After the incubation time DEVD was added to the cell lysates.
Fluorescence was measured in an automatic plate reader with excita-
tion wavelength at 400 nm and emission wavelength at 505 nm. For
positive control, cells were incubated with 5 mM LeuLeuOMe for 12 h.
2.12. Oxidative stress
Oxidative stress was determined by MitoSOX Red (5 μM, 30 min)
and Bodipy 581/591 C11 (2 μM, 30 min) in stably transfected cells.
MitoSOX is oxidized by superoxide anion and exhibits red ﬂuorescence.
Bodipy 581/591 C11 exhibits a shift in ﬂuorescence emission peak from
~590 to ~510 nmafter interactionwith peroxyl radicals. This increase or
shift in ﬂuorescence can be detected by ﬂow cytometry. Stably
transfected SHSY5Y cells were washed with warm PBS, loaded with
Bodipy 581/591 C11 or MitoSOX in PBS for 30 min at 37 °C. Cells were
harvested, pelleted and resuspended in PBS and subjected to FACS anal-
ysis. Dyes were excited using a 488 nm Ar laser and detected with the
FL2 (564–606 nm) or FL1 (515–545 nm) detector, respectively. At
least 7000 cells were acquired for each measurement with three or
four parallels and experiments were independently performed three
times. Bodipy 581/591 C11 was additionally tested under the ﬂuores-
cence microscope.
2.13. Statistical analyses
For statistical analyses Ofﬁce Analysis ToolPak was used employing
Student's t-test: two sample assuming unequal variances. Graphs repre-
sent the mean and s.e.m. of at least three independent experiments.
3. Results
3.1. Inhibitory activity and kinetics of amyloid ﬁbril formation
During isolation and puriﬁcation, the G50E and Q71P mutant were
tested for inhibitory activity with a BANA assay where they exhibited
approximately 10-fold lower activity compared to the wt (Supplemen-
tary Fig. 1).
The time course of amyloid ﬁbril formation was studied by measur-
ing ThT ﬂuorescence versus time. In the presence of 9% of TFE, pH 4.8
and at room temperature, the lag phase for thewt steﬁn Bwas at around
50 h; meanwhile, both G50E and Q71P mutants did not show any lag
phase and started to aggregate swiftly (Fig. 1). Soon after the lag
phase, ﬁbrils prevailed for the wt, while for the mutants, the ﬁbrils
were short (Q71P) or not yet present (G50E). The ﬁnal yield of ﬁbrils
(judged by ThT ﬂuorescence intensity) was also lower for the mutants
than for the wt steﬁn B.Fibril formation was followed in parallel by TEM. Four samples of wt
steﬁn B and the G50E and Q71P mutants were taken for TEM analysis
within approximately the ﬁrst 24 h and one after 2 days. Three samples
were taken on the5th, 6th and on the9th daywhen themutants already
reached the plateau phase, while the wt steﬁn B was still increasing in
ThT ﬂuorescence. The last sample was taken after more than 2 weeks
(16 days) of ﬁbrillation when the reactions reached the plateau phase
(Fig. 1). Only preﬁbrillar aggregates were observed in the ﬁrst 24 h in
the case of G50E mutant (Fig. 2B), whereas in the case of wt steﬁn B
and Q71P mutant (Fig. 2A and C), some ﬁbrils had already grown. All
samples had similar ThT ﬂuorescence at this point. The difference be-
tween these proteins persisted throughout the plateau phase where
only mature ﬁbrils were present in wt steﬁn B, whereas in the G50E
and Q71P mutant samples, some aggregates remained in addition to
short, somewhat stumpy looking ﬁbrils (protoﬁbrils). The protoﬁbrils
of mutants were thicker in diameter compared to the wt. For both
mutants the thickness of protoﬁbrils ranged between 7 and 11 nm.
The average value of G50E protoﬁbrils was 8.68 ± 1.38 nm and of the
Q71P mutant 9.35 ± 0.82 nm. On the other hand, the average value of
wt ﬁbrils was 6.0 ± 0.78 nm ranging between 4.5 and 7.5 nm.3.2. Formation of steﬁn B aggregates in cells
Steﬁn B and chosen EPM1mutants G50E, Q71P, G4R and R68X were
taggedwith T-Sapphire and overexpressed in HEK293T cells for 24 h. At
least 600 (3 × 200 cells) cells with conﬁrmed protein expression were
counted and checked for the aggregate formation. Wt protein formed
very small aggregates/oligomers in only about 5% of all counted cells
(Figs. 3 and 4A). Similar small aggregates were formed by the G4R mu-
tant, whichwere however more abundant and found in about 20% of all
counted cells. The biggest aggregates were found in cells transfected
with R68X, G50E and Q71P mutants. The latter two mutants formed
the highest amount of aggregates (in 65–70% of cells), while R68X
formed aggregates in half of the cells (50%). Table 1 gathers these results
as the amount (%) of cells with the aggregates.
Cells that overexpressed the three most aggregate prone mutants,
i.e. G50E, Q71P and R68X, were also observed to be of round shape
andwith fragmented nucleus that indicated toxicity of these aggregates.
In Fig. 4A, confocal ﬂuorescence images of the wt and EPM1 mutants
G50E and Q71P are shown. No clear expression of G50E and Q71P in
Fig. 2. TEM images in the lag and plateau phases of the ﬁbrillation of the wt steﬁn B (A), G50E mutant (B), and Q71P mutant (C). Samples were taken from the ﬁbrillation reaction at
different time points as marked on the arrows. Protein concentration was 34 μM. The ﬁbrils differed by length and thickness. The average value of wt ﬁbrils was 6 ± 0.78 nm (ranging
between 4.5 and 7.5 nm). The G50E and the Q71P formed shorter protoﬁbrils with a diameter ranging between 7 and 11 nm, namely 8.68 ± 1.38 and 9.35 ± 0.82 nm, respectively.
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formly distributed through the cytoplasm and the nucleus. Cells
remained sedentary with preserved extended shape. No large aggre-
gates were present. Expression of the G50E and Q71P mutant was ob-
served mostly around the nucleus, overtaking a large part of thecytoplasm, especially towards the plasma membrane. Expression levels
of thewt and the G50E andQ71Pmutants upon overexpression (tagged
and untagged forms) were monitored by immunoblotting (Fig. 4B). En-
dogenous steﬁnB levelswere not changed upon overexpression and the
level of tagged steﬁn B forms was lower compared to the endogenous
Fig. 3. Number of cells with steﬁn B aggregates. HEK293T cells were transfected with wt
andmutated variants of steﬁnB. After 24 h of overexpression, at least 600 cellswith visible
protein expression were counted. Estimation of cells with aggregates was made only by
visual inspection. No distinction between large or small aggregates was made.
Fig. 4. (A) Confocal ﬂuorescence microscopy and differential interference contrast (DIC) m
the C-terminus. Samples were observed with a TCS SP5 X confocal microscope and 60× oil o
in HEK293T were monitored by immunoblotting.
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3.3. Cell viability
Cell viability of stably transfected SH-SY5Y cells was tested by ﬂow
cytometry (Figs. 5 and 6). Interestingly, cell viability was the lowest
for two EPM1 mutants that form differently sized aggregates. Even
though we noticed round shape of cells with abundant aggregates of
the G50E, Q71P and R68X mutants, ﬂow cytometry showed that only
the G50E mutant, which produced the highest amount of big aggre-
gates, lowered cell viability to approximately 50% as well as the G4R
mutant, which produced the lowest amount of scattered and diffuse ag-
gregates (Table 1).
This observation correlates with the fact that smaller aggregates of
G4R mutant may be more toxic to cells. The G4R isolated oligomers in
the range of octamers to 12-mers were already shown to be toxic and
to perforate artiﬁcial membranes [54]. In the same paper, wt steﬁn B
oligomers were also shown to be toxic. Our results conﬁrm that
although wt does not produce large aggregates, overexpression of theicroscopy of aggregates in HEK293T cells. All proteins were tagged with T-Sapphire at
bjective. (B) Protein levels of wt and the G50E and Q71Pmutant upon overexpression
Table 1
Characteristics of protein aggregates by expressed proteins.
Characteristics/
Protein
Number of cells
with aggregates
Size of aggregates Cell death Oxidative
stress
WT * * ** ***
G4R * * *** ***
G50E *** *** *** ***
R68X ** *** ** –
Q71P *** *** ** *
Table 1 sums up counted number of cells bearing labeled protein aggregates, an estimate
of their size and their effects on cell viability and oxidative stress, respectively; comparison
is done for thewild type (WT) steﬁnB and its threemissense and one truncatedEPM1mu-
tants. Protein aggregates tagged with green ﬂuorescent protein (GFP) were observed in
HEK293T cells. Cell death and oxidative stress, i.e., lipid peroxidation, were measured in
stably transfected SH-SY5Y cells. Cell death was estimated by ﬂow cytometry.
Legend: *low/small, **medium, ***big/high.
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On average, only 65% of cells survived the overexpression of the wt
protein. The percentage of live cells was similar for the cells with
overexpressed mutated proteins R68X and Q71P, which produced big
perinuclear aggregates.
Cells were PI and AnnexinV positive or only PI positive, meaning
they could be either in late apoptotic or in necrotic stage, respectively
(Fig. 6). However, no caspase-3-like activity was detected (Supplemen-
tary Fig. 2) meaning that cells were dying by caspase-independent cell
death, most likely by necrosis. Our results thus show that the amount
of aggregates does not correlate with cell death but it is most probably
the characteristics of the oligomers/aggregates that deﬁne the cell fate
and direct it to the cell death pathway.We later discuss themorphology
of the aggregates as observed by TEM.
3.4. Measuring oxidative stress
Oxidative stress was measured by Bodipy 581/591 C11 and MitoSOX
Red in SH-SY5Y cells. With Bodipy 581/591 C11 oxidative stress can be
measured indirectly by determining peroxidation of lipids. When re-
duced, this dye exhibits red ﬂuorescence andwhen oxidized, its emission
peak shifts to the green spectrum.MitoSOX speciﬁcally targets superoxide
anions, which are the predominant ROS (reactive oxygen species) gener-
ated in the mitochondria, and exhibits red ﬂuorescence when oxidized.
Firstly, SH-SY5Y cell were transiently transfected with different con-
structs and dyed with Bodipy 581/591 C11 after 24 h of overexpression.
Microscopy imaging showed whole cell or only localized sites of lipid
peroxidation (Fig. 7). Secondly, the results were validated with stablyFig. 5. Bar graph presentation of cell viability of stably transfected SH-SY5Y cells. Cell
viability was measured on ﬂow cytometer using annexin V and propidium iodide (PI)
dyes. Control = untransfected cells, plasmid = cells transfected with an empty pcDNA3
plasmid. Student's t-test, ***p b 0.01.transfected SH-SY5Y cell. The ﬂuorescence intensity of Bodipy 581/591
C11 was measured by ﬂow cytometry. Flow cytometry measurements
showed a correlation between cell viability (Figs. 5 and 6) and oxidative
stress (Figs. 8 and 9) for certain EPM1missense mutants. As gathered in
Fig. 9, surprisingly, overexpression of the wt protein caused one of the
highest increases in lipid peroxidation but this did not result in massive
cell death—at least not compared to the G50E and G4R mutants who
showed the highest amount of lipid peroxidation (Fig. 9) but also the
highest cell death (Fig. 5). Q71P and R68X mutants did not exhibit rele-
vant shifts in ﬂuorescence (Fig. 8), and thus did not produce additional
ROS formation. With MitoSOX Red, no signiﬁcant increase in ﬂuores-
cencewas detected,meaning that steﬁn B aggregates do not signiﬁcantly
inﬂuence or damage mitochondrial membranes (Supplementary Figs. 3
and 4).
3.5. TEM images of steﬁn B aggregates in transfected cells
CHO cells were used to study the characteristics of aggregates be-
cause they do not contain endogenous steﬁn B protein. No long ﬁbrils
of transfected steﬁn Bmutants, resembling the ﬁbrils formed during ki-
netic studies in vitro inmildly acidic environment (Fig. 2),were found in
transfected CHO cells (Fig. 10). Nevertheless, upon overexpression of
Q71P (Fig. 10A) and G50E (Fig. 10B), a noticeable protein aggregation
that was morphologically distinguished from adjacent cytoplasm due
to heavy uranyl acetate binding to the aggregated proteinwas observed
compared to non-transfected control sample (not shown).
The spherical aggregate of Q71P (Fig. 10A) showsmore than 500 nm
in diameter whereas the unevenly shaped aggregates of G50E (Fig. 10B)
are of smaller size (200–400 nm). Since uranyl acetate contrasts all pro-
teins (but not the lipid membranes) we cannot exclude that the pro-
teins within the aggregates were only steﬁn B mutants or there might
be some other proteins in addition. Still, immunogold labeling with
anti-human steﬁn B antibody clearly conﬁrmed the localization and
high content of O71P (Fig. 10A) as well as G50E (Fig. 10B) within the
immunogold labeled aggregates.
The amorphous structure of the labeled aggregates (Fig. 10A and B)
is not homogenous and it does not look that the aggregates would be
surrounded by a membrane. Another type of aggregates formed by
the R68X mutant was found to be surrounded by membranes and to
partially colocalize with microtubule-associated protein light chain 3
(LC3). LC3 is an autophagy marker indicated that these aggregates are
targeted for autophagic degradation [55].
With these data (Fig. 10) we can further conﬁrm that the aggrega-
tion of steﬁn B mutants Q71P and G50E (Fig. 4A) was not associated
with the ﬂuorophore tag but rather resulted from the steﬁnB EPM1mu-
tants' proneness to form oligomers/aggregates.
4. Discussion
In vitro characterization of EPM1 mutants G50E and Q71P has par-
tially already been studied and it has been shown that both mutants
possess similar secondary structure than the wt, whereas the tertiary
structure is partially unfolded. This especially holds true for the Q71P
mutant that has increased hydrophobic surfaces [56]. The G4R mutant,
albeit inactive like the G50E and Q71P mutants (Supplementary Fig. 1),
has the same secondary and tertiary structure as thewt and is of similar
stability than the wt [57]. The R68X fragment is on the other hand
completely unfolded and R68X forms amyloid-ﬁbrils very fast even at
neutral pH and under mild conditions [57]. The G4R mutant exhibits a
prolonged lag phase compared to the wt, during which preﬁbrillar ag-
gregates accumulate [57].
Both of the newly studied missense mutants G50E and Q71P ﬁbril-
lated in vitro in the slightly acidic environment with the addition of
9% TFE (Figs. 1 and 2B and C), as was previously shown for the wt
[57]. The ﬁbrillation kinetics was similar for both mutants, without a
lag phase. The reaction toﬁbrilswas not complete; it ended as amixture
Fig. 6. Annexin V and PI ﬂuorescence measurements of cell viability by ﬂow cytometry on stably transfected SH-SY5Y cells. Live cells are annexin V and PI negative, thus in lower left
quadrant. Necrotic and/or late apoptotic cells appear in the upper two quadrants. All experiments were repeated three times. The representative results of one experiment are shown.
Control = untransfected cells; plasmid control = cells transfected with an empty pcDNA3 plasmid.
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be observed. This also could explain the low ThTﬂuorescence compared
to the wt in the ﬁnal plateau phase (Fig. 1). The reaction ended with
protoﬁbrils, which were thicker than the wt ﬁbrils. In more details:
the protoﬁbrils of themutantswere shorter, thicker and stumpy lookingFig. 7. Fluorescence images of SH-SY5Y cells stainedwith Bodipy 581/591 C11. Cellswere transie
C11 (2 μM, 30 min). A: control, non-transfected cells, B: cells transfected with an empty pcDN
positive control (1 mM H2O2, 30 min). Green and red emission were ﬁltered using U-N4900
Scale bar: 20 μm.(around 9 nm in diameter) (Fig. 2B and C) compared to the wt that
formed thinner (around 6 nm), but denser and longer ﬁbrils (Fig. 2A).
Evidence exists that soluble, preﬁbrillar aggregates are more
cytotoxic than mature and insoluble amyloid ﬁbrils. Moreover, ﬁbrils
(stuck in the aggresomes) or amyloid plaques are a protectivently transfectedwith different steﬁn Bmutants and after 24 h stainedwith Bodipy 581/591
A3 plasmid, C: wt, D: G4R mutant, E: G50E mutant, F: R68X mutant, G: Q71P mutant, H:
2 and U-N41002 ﬁlter cubes and merged images of two ﬂuorescence signals are shown.
Fig. 8. Shift in Bodipy 581/591 C11 ﬂuorescencemeasured by ﬂow cytometer. Bodipy 581/591 C11 was excited using a 488 nmAr laser and detected on a FL1 (515–545 nm) photodetector
onﬂowcytometer. A: negative versus positive control; B: negative versus plasmid control; C: plasmid versus positive control; D: plasmid control versuswt; E: plasmid control versus G4R;
F: plasmid versus G50E; G: plasmid versus R68X; H: plasmid versus Q71P. Negative control = untransfected cells; plasmid= cells transfected with an empty pcDNA3 plasmid; positive
control = untransfected cell treated with 1 mM H2O2 for 30 min. All experiments were repeated three times. The representative results of one experiment are shown.
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Q71P mutants could thus indicate potential cytotoxic effects. Cellular
studies indeed conﬁrmed a higher cytotoxicity, especially so of the
G50E (see, three paragraphs below).
In our previous cellular studies, G4R formed small and diffuse aggre-
gates while aggregates of the R68X mutant were bigger, vesicular and
perinuclear [55]. In order to study G50E and Q71P mutants, HEK293T
and SH-SY5Y cells were used for transfection and the effects of protein
aggregation on cells were observed. Both G50E and Q71P mutants
formed big perinuclear aggregates compared to the wt which formed
few and very little aggregates upon overexpression in HEK293T cells
(Figs. 3 and 4A and Table 1). The R68Xmutant was expressed alongside
for comparison, knowing that it is inactive, without any tertiary struc-
ture and that it undergoes ﬁbril formation very quickly. The fourth
EPM1mutant, G4R, was used as another comparison. It also loses its in-
hibitory activity but it keeps its tertiary structure complete [57].
Imaging by confocal microscopy of EPM1mutants G50E and Q71P in
comparison to thewt (Fig. 4A) showed that the aggregates in cells are of
two types. Bigger and perinuclear aggregates of G50E, Q71P (previously
also observed for R68X [55]), or smaller, punctual and dispersed
throughout the cytoplasm similar as for wt and G4R proteins [55].
TEM images (Fig. 10) of the aggregates immunogold labeled with
speciﬁc anti-steﬁn B antibody and protein A-gold conﬁrmed that non-
taggedQ71P andG50Emutants form rather big cytoplasmic aggregates;
however, the shown examples are likely not aggresomes as they do not
localize in vicinity of the nucleus and lipidmembranes cannot be clearlyFig. 9. Fluorescence intensity of Bodipy 581/591 C11 (mean) measured by ﬂow cytometry
on stably transfected SH-SY5Y cells. Bodipy 581/591 C11 was excited using a 488 nm Ar
laser and detected on a FL1 photodetector (515–545 nm) on ﬂow cytometer. Plasmid =
cells transfected with an empty pcDNA3 plasmid, negative = untransfected cells,
positive = untransfected cells treated with 1 mM H2O2 for 30 min. Student's t-test,
*p b 0.1, **p b 0.05, ***p b 0.01.observed. Interestingly, in addition to gold labeled aggregates of the
Q71P mutant in the cytoplasm, no signiﬁcant number of gold particles
was observed inside large vesicular organelles with abundant internal
membranes (Supplementary Fig. 5), most probably representing a
population of lysosome-like vesicles.
For the purpose ofmeasuring cell viability, SH-SY5Y cellswere stably
transfected with non-tagged wt steﬁn B and its four EPM1 mutants.
Flow cytometry results showed that cell viability decreased in all cells
compared to the controls (Figs. 5 and 6) and was the lowest (~50%)
for the G50E and G4R mutants. The Q71P and R68X mutants reduced
the cell viability to about 70%. Thus, cell viability did not correlate
with the size and number of the aggregates in cells. We hypothesize
that this is due to the exposed hydrophobic surfaces (Q71P) and the
complete loss of the tertiary structure (R68X), which implies that
these mutants aggregate very quickly and cause less damage than the
aggregates that aggregate slowly (G50E) or form small cytotoxic
oligomers (G4R) [54]. Interestingly, overexpression of the wt protein
also reduced cell viability. This could be due to the formation of small
oligomers (but higher than the tetramers which are not toxic) that
were shown to be cytotoxic and to perforate membranes [50,54].
Cellswere either only PI positive or Annexin V and PI positive,mean-
ing that caspase-independent cell death (e.g. necrosis)was the predom-
inant cell death pathway. This was conﬁrmed by testing DEVDase
activity, a marker for apoptotic cell death (Supplementary Fig. 2). We
think that necrotic cell death could be the consequence of increased ox-
idative stress. There is no consensus on what is the predominant cell
death pathway in neurodegeneration; however, calpain and cathepsin
activation may have an important role in necrotic neuronal cell death
[6].
Oxidative stress has long been linked to neuronal cell death in neu-
rodegenerative diseases. For some time it was unclear whether it is a
primary cause or merely a downstream consequence of the neurode-
generative process (for review see [60]); however, a consensus was
reached in the last years that excess ROS generation appears in most
neurodegenerative diseases before cell death [61,62]. Furthermore, sen-
sitivity to oxidative stress has been connected to steﬁn B deﬁciency in a
neuronal [34] and breast cancer cell model [35].
To detect oxidative stress, steﬁn B mutants and the wt were
overexpressed in SH-SY5Y cells and Bodipy 581/591 C11 dye andMitSOX
Redwere used as probes.MitoSOXRed speciﬁcally targetsmitochondrial
superoxide anions; however, no ROS originating from the mitochondria
were detected (Supplementary Figs. 3 and 4). Aggregates and oligomers
thus did not affect or perforate mitochondrial membranes.
Bodipy 581/591 C11 is a ﬂuorescent probe for labeling lipid peroxida-
tion. SH-SY5Y cells with transiently overexpressed steﬁn B mutants
were observed by ﬂuorescence microscope. Images showed mostly lo-
calized increase in ROS generation (Fig. 7). This increase happened
within the ﬁrst 24 h of protein overexpression and aggregate formation.
Further, ﬂow cytometry measurements on cells with stable protein
Fig. 10. Transmission electron microscopy (TEM) of steﬁn B mutants Q71P (A) and G50E (B), both transfected in CHO cells. Ultra-thin sections (70 nm) were immunogold labeled with
rabbit anti-steﬁnB antibody and Protein A-gold (10 nm). Cell proteinswere contrastedwith uranyl acetate. Aggregatedproteins (*) and theposition of gold particles (arrows) are denoted.
Bars represent 200 nm.
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G4R mutants (Figs. 8 and 9) that also gave the lowest cell viability
(Fig. 5). The amount of lipid peroxidation in R68X and Q71P expressing
cells statistically did not differ from the control group, although Q71P
mutant had a high statistical error of themeasurement and no ﬁrm con-
clusion could be met. Interestingly, overexpression of the wt steﬁn B
protein caused the highest amount of lipid peroxidation (Fig. 9) that
also reduced cell viability but not as much as the expression of the
G4R and G50E mutants (Fig. 5). The results show that even though wt
steﬁn B oligomers have been shown to be cytotoxic [50] and apparently
increase oxidative stress, its oligomers are not as cytotoxic as the ones
from the G4R and G50E mutants. Also, the protective mechanisms that
normally rescue cells from cell death comprising thewt steﬁnB function
must be still in place, thus preventing cell death.
One should be aware that overexpression of steﬁn B gene and pro-
tein happens in vivo by various insults, among them epileptic seizures.
That steﬁn Bmay be protective in those conditions is possible; however,
it may also contribute to more damage by increasing oxidative stress.
On the other hand, steﬁn B KO animals have increased neuronal cell
death of granule cells in the cerebellum [63] and KO cells show in-
creased sensitivity to ROS [34,35]. The balanced expression of this pro-
tein and its proper localization and function in signaling must all be
understood to explain the beneﬁcial effects of steﬁn B. The still unre-
solved alternative function in the nucleus will also help to understand
its cellular role in health and disease.
Whenmutations of the transcript region appear in EPM1 it is usually
only on one allele while on the other allele the most common
dodecamer repeat expansion in the promoter region is found. Even
though the pathological mutants get expressed to only about 15–35%
[12] we think that the formation of the aggregates can still modulate
the pathology. Speciﬁcally for the G50E protein, it was shown to have
a relatively high expression in EPM1 patients [64]. However, it is of
note that patients bearing the R68X mutation on one of the alleles
showmore severe pathology and clinical symptoms [65]. These ﬁndings
thus leave an open question, whether the bigger aggregates that can se-
quester other proteins from the cytoplasm or oligomers/smaller aggre-
gates scattered in the cytoplasm are more damaging.
In conclusion: 1. The protein aggregates of the EPM1 mutants of
human steﬁn B can be taken as a model for protein aggregation in
cells and their degradation and toxic effects may be of general interest.
2. No clear correlation with the size or number of aggregates and cell
death was shown, whereas correlation to oxidative stress was found.
We propose that the smaller and more diffuse, scattered aggregates
throughout the cytoplasm of the wt protein, G50E and G4R mutant
(which are all folded proteins and oligomer-prone) may bind to mem-
branes and cause increase in ROS that could lead to necrotic cell death.
3. Although the expression of the missense EPM1 mutants in patientsis not high (up to 40% of the normal protein level), the aggregates cyto-
toxicitymay contribute to EPM1 disease.We propose that in addition to
loss of steﬁn B normal function, gain in toxic function of the aggregates
may occur.
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